CT and MR imaging of chemotherapy-induced hepatopathy

Massimo Midiri, Giuseppe Badalamenti, Federica Vernuccio, Giuseppe Brancatelli, Federica Vernuccio, Marco Dioguardi Burgio, Silvestro Cusmà, Filippo Barbiera, Valérie Vilgrain, Marco Dioguardi Burgio

Risultato della ricerca: Article

Abstract

Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-induced changes on CT and MR imaging.
Lingua originaleEnglish
pagine (da-a)3312-3324
Numero di pagine13
RivistaAbdominal Radiology
Volume44
Stato di pubblicazionePublished - 2019

Fingerprint

Drug Therapy
Liver
Blood Vessels
Hepatitis
Fibrosis
Neoplasm Metastasis
Radiologists

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Cita questo

Midiri, M., Badalamenti, G., Vernuccio, F., Brancatelli, G., Vernuccio, F., Dioguardi Burgio, M., ... Dioguardi Burgio, M. (2019). CT and MR imaging of chemotherapy-induced hepatopathy. Abdominal Radiology, 44, 3312-3324.

CT and MR imaging of chemotherapy-induced hepatopathy. / Midiri, Massimo; Badalamenti, Giuseppe; Vernuccio, Federica; Brancatelli, Giuseppe; Vernuccio, Federica; Dioguardi Burgio, Marco; Cusmà, Silvestro; Barbiera, Filippo; Vilgrain, Valérie; Dioguardi Burgio, Marco.

In: Abdominal Radiology, Vol. 44, 2019, pag. 3312-3324.

Risultato della ricerca: Article

Midiri, M, Badalamenti, G, Vernuccio, F, Brancatelli, G, Vernuccio, F, Dioguardi Burgio, M, Cusmà, S, Barbiera, F, Vilgrain, V & Dioguardi Burgio, M 2019, 'CT and MR imaging of chemotherapy-induced hepatopathy', Abdominal Radiology, vol. 44, pagg. 3312-3324.
Midiri, Massimo ; Badalamenti, Giuseppe ; Vernuccio, Federica ; Brancatelli, Giuseppe ; Vernuccio, Federica ; Dioguardi Burgio, Marco ; Cusmà, Silvestro ; Barbiera, Filippo ; Vilgrain, Valérie ; Dioguardi Burgio, Marco. / CT and MR imaging of chemotherapy-induced hepatopathy. In: Abdominal Radiology. 2019 ; Vol. 44. pagg. 3312-3324.
@article{f1ab0ca9664e4fb584f240caf3c0d7be,
title = "CT and MR imaging of chemotherapy-induced hepatopathy",
abstract = "Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-induced changes on CT and MR imaging.",
author = "Massimo Midiri and Giuseppe Badalamenti and Federica Vernuccio and Giuseppe Brancatelli and Federica Vernuccio and {Dioguardi Burgio}, Marco and Silvestro Cusm{\`a} and Filippo Barbiera and Val{\'e}rie Vilgrain and {Dioguardi Burgio}, Marco",
year = "2019",
language = "English",
volume = "44",
pages = "3312--3324",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",

}

TY - JOUR

T1 - CT and MR imaging of chemotherapy-induced hepatopathy

AU - Midiri, Massimo

AU - Badalamenti, Giuseppe

AU - Vernuccio, Federica

AU - Brancatelli, Giuseppe

AU - Vernuccio, Federica

AU - Dioguardi Burgio, Marco

AU - Cusmà, Silvestro

AU - Barbiera, Filippo

AU - Vilgrain, Valérie

AU - Dioguardi Burgio, Marco

PY - 2019

Y1 - 2019

N2 - Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-induced changes on CT and MR imaging.

AB - Chemotherapy-induced hepatopathy includes a wide variety of parenchymal and vascular hepatic changes on imaging, including diffuse or focal hepatopathies (i.e. hepatitis, steatosis, fibrosis, pseudocirrhosis, or sinusoidal obstruction). These changes can profoundly alter the hepatic parenchyma on imaging and result in both false negative and false-positive diagnoses of hepatic metastases and lead to errors in patient management strategies. It is therefore important for radiologists to have a comprehensive knowledge of the imaging patterns that may develop following chemotherapy. The purpose of this review is to explore the broad spectrum of hepatic parenchymal and vascular chemotherapy-induced changes on CT and MR imaging.

UR - http://hdl.handle.net/10447/367528

M3 - Article

VL - 44

SP - 3312

EP - 3324

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

ER -